Ophiomics was delighted to host the LEOPARD Project’s First Annual Meeting in Lisbon last week! We’re proud to share a common mission with our partners: to improve outcomes for liver transplant patients by redefining organ allocation in Europe and shaping future clinical guidelines through data-driven innovation and collaboration.
Related Posts
👏💪 It’s out! Our latest study addresses a critical need in gastroenterology: early and accurate identification of Barrett’s Esophagus (BE)
We’re excited to announce that HepatoPredict, our CE-IVD prognostic tool to assess hepatocellular carcinoma (HCC) recurrence in the context of
HepatoDetect Shows Strong Potential for Early HCC Detection HepatoDetect, our AI-driven liquid biopsy platform designed for the early detection of
Now partnering with global institutions and investors to scale innovation where it matters most. Ophiomics is building the world’s first
+351 211 369 829 